Literature DB >> 20688947

Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin.

Romney M Humphries1, Theodoros Kelesidis2, Jennifer Dien Bard1, Kevin W Ward3, Debika Bhattacharya2, Michael A Lewinski1.   

Abstract

The spread of antimicrobial resistance among members of the Enterobacteriaceae is a significant clinical threat. We report the treatment of pan-resistant Klebsiella pneumoniae bacteraemia with combination tigecycline and colistin in a 49-year-old male and review available therapeutic options. Despite a poor prognosis, the patient recovered, but remains colonized with the pan-resistant isolate.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20688947      PMCID： PMC8482875          DOI： 10.1099/jmm.0.023010-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   3.196


  13 in total

Review 1.  Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines.

Authors:  Kenneth N Agwuh; Alasdair MacGowan
Journal:  J Antimicrob Chemother       Date:  2006-07-01       Impact factor: 5.790

2.  Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis.

Authors:  Burke A Cunha
Journal:  J Clin Microbiol       Date:  2009-05       Impact factor: 5.948

3.  In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.

Authors:  Marc H Scheetz; Chao Qi; John R Warren; Michael J Postelnick; Teresa Zembower; Arlene Obias; Gary A Noskin
Journal:  Antimicrob Agents Chemother       Date:  2007-02-16       Impact factor: 5.191

4.  Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.

Authors:  Federico Perez; Andrea Endimiani; Amy J Ray; Brooke K Decker; Christopher J Wallace; Kristine M Hujer; David J Ecker; Mark D Adams; Philip Toltzis; Michael J Dul; Anne Windau; Saralee Bajaksouzian; Michael R Jacobs; Robert A Salata; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2010-05-31       Impact factor: 5.790

Review 5.  Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies.

Authors:  Theodoros Kelesidis; Drosos E Karageorgopoulos; Iosif Kelesidis; Matthew E Falagas
Journal:  J Antimicrob Chemother       Date:  2008-08-01       Impact factor: 5.790

6.  A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.

Authors:  Krasimir Vasilev; Galina Reshedko; Remus Orasan; Miguel Sanchez; Juri Teras; Tim Babinchak; Gary Dukart; Angel Cooper; Nathalie Dartois; Hassan Gandjini; Russ Orrico; Evelyn Ellis-Grosse
Journal:  J Antimicrob Chemother       Date:  2008-09       Impact factor: 5.790

Review 7.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.

Authors:  Patrice Nordmann; Gaelle Cuzon; Thierry Naas
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

8.  Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.

Authors:  Brandon Kitchel; J Kamile Rasheed; Jean B Patel; Arjun Srinivasan; Shiri Navon-Venezia; Yehuda Carmeli; Alma Brolund; Christian G Giske
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

9.  Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae.

Authors:  Sandeep Kochar; Timothy Sheard; Roopali Sharma; Alan Hui; Elaine Tolentino; George Allen; David Landman; Simona Bratu; Michael Augenbraun; John Quale
Journal:  Infect Control Hosp Epidemiol       Date:  2009-05       Impact factor: 3.254

10.  Clonal dissemination of Klebsiella pneumoniae carbapenemase KPC-3 in Long Beach, California.

Authors:  Jennifer Le; Mariana Castanheira; David S Burgess; Barbara McKee; Raza Iqbal; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2009-12-23       Impact factor: 5.948
View more
  19 in total

1.  High-dose tigecycline and colistin for successful treatment of disseminated carbapenem-resistant Klebsiella pneumoniae infection in a liver transplant recipient.

Authors:  Jennifer Marie Dan; Michel Henry Mendler; Alan W Hemming; Saima Aslam
Journal:  BMJ Case Rep       Date:  2014-11-05

2.  Intestinal decontamination of multidrug-resistant Klebsiella pneumoniae after recurrent infections in an immunocompromised host.

Authors:  Matthew P Kronman; Danielle M Zerr; Xuan Qin; Janet Englund; Cathy Cornell; Jean E Sanders; Jeffrey Myers; Jaipreet Rayar; Jessica E Berry; Amanda L Adler; Scott J Weissman
Journal:  Diagn Microbiol Infect Dis       Date:  2014-06-21       Impact factor: 2.803

Review 3.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 4.  Nanotargeting of Resistant Infections with a Special Emphasis on the Biofilm Landscape.

Authors:  Amjed Alabresm; Savannah L Chandler; Brian C Benicewicz; Alan W Decho
Journal:  Bioconjug Chem       Date:  2021-07-28       Impact factor: 4.774

5.  Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance.

Authors:  Luke F Chen; Deverick J Anderson; David L Paterson
Journal:  Infect Drug Resist       Date:  2012-09-24       Impact factor: 4.003

Review 6.  Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.

Authors:  Grace C Lee; David S Burgess
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-12-13       Impact factor: 3.944

7.  Polymyxin Combination Therapy and the Use of Serum Bactericidal Titers in the Management of KPC-Producing Klebsiella pneumoniae Infections: A Report of 3 Cases.

Authors:  Eric Gomez; Martha Sanchez; Zonaira Gul; Carl Urban; Noriel Mariano; Robert H K Eng; David B Huang; Tom Chiang
Journal:  Case Rep Med       Date:  2011-11-28

Review 8.  New Delhi Metallo-beta lactamase-1 containing enterobacteriaceae: origin, diagnosis, treatment and public health concern.

Authors:  Jaykaran Charan; Summaiya Mulla; Sridhar Ryavanki; Naresh Kantharia
Journal:  Pan Afr Med J       Date:  2012-02-13

9.  Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010.

Authors:  Guillermo V Sanchez; Ronald N Master; Richard B Clark; Madiha Fyyaz; Padmaraj Duvvuri; Gupta Ekta; Jose Bordon
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

10.  High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria.

Authors:  Gennaro De Pascale; Luca Montini; Mariano Pennisi; Valentina Bernini; Riccardo Maviglia; Giuseppe Bello; Teresa Spanu; Mario Tumbarello; Massimo Antonelli
Journal:  Crit Care       Date:  2014-05-05       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.